Becker's Healthcare February 27, 2025
Andrew Cass

Private equity firm Sycamore Partners plans to split Walgreens Boots Alliance into three independent businesses if it successfully acquires the drugstore chain private, The Financial Times reported Feb. 27.

The company would initially be taken private as a whole, but Sycamore ultimately plans to make Walgreens, UK chemist and retailer Boots, and specialty pharmacy business Shield Health Solutions into independent units with distinct capital structures, according to the report.

Sycamore’s potential acquisition of Walgreens was first reported in December. Acquisition talks have been complicated by the volatility in Walgreens’ share price and the deal could still collapse in the coming weeks, people close to the discussion told The Financial Times.

On Jan. 27, CNBC’s David Faber said...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M
The Current, Future Roles of AI within the Pharmacy Profession
A new era of Made in America drug manufacturing
Eli Lilly to invest $27B in manufacturing
FTC Finds PBM-Owned Pharmacies Marked Up Generic Specialty Drugs by $7.3 Billion

Share This Article